Hyperuricemia and gout non-drug targeted intervention system based on molecular subtyping

A technology for hyperuricemia and molecular typing, applied in the field of non-drug targeted intervention, can solve problems such as unsatisfactory and neglected uric acid effects, and achieve the effects of preventing gout, reducing blood uric acid concentration, and reducing blood uric acid.

Active Publication Date: 2018-08-03
西安时代基因健康科技股份有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, relying on drug treatment, ignoring the important influence of hyperuricemia, gout risk factors and major genetic defects on the increase of uric acid in the body, ignoring the intervention of uric acid metabolism function, so the effect of reducing uric acid is not satisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hyperuricemia and gout non-drug targeted intervention system based on molecular subtyping

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] The present invention will be described in detail below in conjunction with the accompanying drawings and embodiments. The examples are to explain the present invention, not to limit the present invention.

[0027] see figure 1 , non-drug targeted intervention process for hyperuricemia and gout based on molecular typing, including the following steps:

[0028] 1) Comprehensive collection of hyperuricemia & gout risk factors

[0029] Risk factors include personal health status, personal and family history of hyperuricemia and gout, secondary risk factors (diseases associated with elevated uric acid, such as obesity; drugs) and primary risk factors (lifestyle and environmental factors , such as high-purine diet, alcohol consumption; genetic factors, such as gene mutations in the key pathway of uric acid excretion). Among them, the key pathway genes of uric acid excretion include uric acid secretion protein ABCG2 and uric acid reabsorption protein SLC2A9 genes. In addi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a hyperuricemia and gout non-drug targeted intervention system based on molecular subtyping, and the system employs a method which comprises the steps: danger factor collection, molecular subtyping, risk grouping and intervention scheme formulation. The system enables a hyperuricemia and gout molecular pathogenesis, a clinical pathogenesis and a non-drug interventional mechanism to be connected, and integrates other factors under the guide of molecular subtyping for the risk evaluation and population grouping, so as to provide a non-drug means for the targeted intervention of a molecular subtyping target point. The system can improve the uric acid metabolism of a human body, reduces the concentration of blood uric acid, and achieves the molecular diagnosis for precisely reducing uric acid and the targeted intervention for the efficient prevention of gout.

Description

technical field [0001] The invention belongs to the technical field of medical services and relates to non-drug targeted intervention under the guidance of hyperuricemia and gout molecular typing. Background technique [0002] Hyperuricemia (HUA) is a chronic metabolic disease caused by purine metabolism disorder, which is the most important biochemical basis and the most direct cause of gout. People with hyperuricemia develop urate crystal deposits that lead to arthritis (gouty arthritis), uric acid nephropathy, and kidney stones called gout. [0003] With the development of society and economy, the change of people's lifestyle and dietary structure, the prevalence of hyperuricemia is increasing year by year, and the incidence increases with age, and the affected population is showing a younger trend. At present, hyperuricemia has become the second largest metabolic disease after diabetes. [0004] The causes of hyperuricemia and gout are complex and diverse. Primary hyp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G16H50/20G16H50/30G16H70/00
CPCG16H50/20G16H50/30G16H70/00
Inventor 孟涛
Owner 西安时代基因健康科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products